1.
Zh Mikrobiol Epidemiol Immunobiol
; (11): 39-41, 1991 Nov.
Artigo
em Russo
| MEDLINE
| ID: mdl-1811387
RESUMO
The trial of experimental vaccine consisting of protective protein antigens of P. aeruginosa cell wall was carried out on 114 volunteers. The vaccine proved to be faintly reactogenic and induced the formation of specific humoral immunity in 98% of the volunteers who retained a high level of anti-P. aeruginosa antibodies in their blood for up to 5 months (the term of observation after the course of immunization was over.